Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms.

Autor: Gurban P; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Cytogenomic Medical Laboratory, Bucharest, Romania., Mambet C; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Emergency University Clinical Hospital, Bucharest, Romania., Botezatu A; Molecular Virology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Necula LG; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Matei L; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Neagu AI; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Infectious Diseases, Epidemiology, Microbiology, Parasitology, Virology, Diabetes, Endocrinology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Pitica I; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Ataman M; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Tatic A; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Bardas A; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Gaman MA; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Dobrea C; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Dragomir M; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Ghimici C; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Angelescu S; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Barbu D; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Stanca O; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Danila M; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Berbec N; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Colita A; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Coltea Clinical Hospital, Bucharest, Romania., Vladareanu AM; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Hematology Department, Emergency University Clinical Hospital, Bucharest, Romania., Nedeianu S; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Chivu-Economescu M; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Bleotu C; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Coriu D; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania.; Department of Radiology, Oncology, and Hematology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Sepulchre E; de Duve Institute, Université catholique de Louvain, Brussels, Belgium., Anton G; Molecular Virology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Diaconu CC; Cellular and Molecular Pathology Department, Stefan S. Nicolau Institute of Virology, Romanian Academy, Bucharest, Romania., Constantinescu SN; de Duve Institute, Université catholique de Louvain, Brussels, Belgium.; SIGN (Cell Signalling and Molecular Hematology), Ludwig Institute for Cancer Research Brussels, Brussels, Belgium.; Walloon Excellence in Life Sciences and Biotechnology (WELBIO) Department, WEL Research Institute, Wavre, Belgium.; Nuffield Department of Medicine, Ludwig Institute for Cancer Research, Oxford University, Oxford, UK.

Publikováno v: American journal of hematology [Am J Hematol] 2025 Jan; Vol. 100 (1), pp. 168-171. Date of Electronic Publication: 2024 Oct 19.

Atypical Presentation for Adult T-Cell Leukemia/Lymphoma: a Case Report and Short Review of the Literature.

Autor: Iordan I; Department of Hematology, 'Carol Davila' University of Medicine and Pharmacy, Emergency University Hospital, Bucharest, Romania.; Department of Medical Semiology and Nephrology, 'Carol Davila' University of Medicine and Pharmacy, Emergency University Hospital, Bucharest, Romania., Vladareanu AM; Department of Hematology, 'Carol Davila' University of Medicine and Pharmacy, Emergency University Hospital, Bucharest, Romania., Mambet C; Department of Hematology, 'Carol Davila' University of Medicine and Pharmacy, Emergency University Hospital, Bucharest, Romania.; Department of Virology, 'Stefan S. Nicolau' Institute, Bucharest, Romania., Dumitru I; Department of Hematology, 'Carol Davila' University of Medicine and Pharmacy, Emergency University Hospital, Bucharest, Romania., Onisai M; Department of Hematology, 'Carol Davila' University of Medicine and Pharmacy, Emergency University Hospital, Bucharest, Romania., Cisleanu D; Department of Hematology, 'Carol Davila' University of Medicine and Pharmacy, Emergency University Hospital, Bucharest, Romania., Bumbea H; Department of Hematology, 'Carol Davila' University of Medicine and Pharmacy, Emergency University Hospital, Bucharest, Romania.

Publikováno v: Maedica [Maedica (Bucur)] 2024 Jun; Vol. 19 (2), pp. 428-433.

Proinflammatory role of monocytes in SARS-CoV-2 infection in chronic hemodialysis patients.

Autor: Bumbea V; Department of Dialysis, Emergency Clinical Hospital Bucharest, Bucharest, Romania., Ardelean L; Department of Dialysis, Emergency Clinical Hospital Bucharest, Bucharest, Romania., Radulescu L; Department of Dialysis, Emergency Clinical Hospital Bucharest, Bucharest, Romania., Damian L; Department of Nephrology, Emergency University Hospital Bucharest, Bucharest, Romania., Bumbea H; Department Hematology, Emergency University Hospital Bucharest, Bucharest, Romania.; University of Medicine and Pharmacy Carol Davila Bucharest, Bucharest, Romania., Dumitru I; Department Hematology, Emergency University Hospital Bucharest, Bucharest, Romania.; University of Medicine and Pharmacy Carol Davila Bucharest, Bucharest, Romania., Lambert C; Department Immunology, Centre Hospitalier Universitaire (CHU) de Saint Etienne, Saint Etienne, France., Vladareanu AM; Department Hematology, Emergency University Hospital Bucharest, Bucharest, Romania.; University of Medicine and Pharmacy Carol Davila Bucharest, Bucharest, Romania.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Aug 03; Vol. 14, pp. 1210961. Date of Electronic Publication: 2023 Aug 03 (Print Publication: 2023).

Chronic lymphocytic leukemia followed by myelodysplastic syndrome and erythroleukemia

Autor: Cazaceanu, O, Iova, A, Vladareanu, AM, Onisai, M, Enache, C, Andrus, E

Publikováno v: Journal of Medicine and Life

CLL patients are more exposed to develop a second neoplasm, but the association. CLL-MDS is an unusual one. We present the case of a 61-year-old male patient, diagnosed with chronic lymphocytic leukemia in 2007, who developed myelodysplastic features

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8aac97727910b305d67463add1fe32fa
https://pubmed.ncbi.nlm.nih.gov/31803279

Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses

Autor: Ciufu, C, Arama, V, Bumbea, H, Dobrea, C, Ion, I, Vladareanu, AM

Publikováno v: Journal of Medicine and Life

Background. Hepatitis B and C viruses’ infections are often associated with hematological disorders in evolution, suggesting that these viruses have a tropism for peripheral blood and/or bone marrow cells. Aim. To analyze the hematological paramete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c6f4b865c9af1b78e62883c301800c54
http://europepmc.org/articles/PMC4034312